Financhill
Sell
17

MRAI Quote, Financials, Valuation and Earnings

Last price:
$0.47
Seasonality move :
12.26%
Day range:
$0.46 - $0.56
52-week range:
$0.34 - $1.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.35x
P/B ratio:
--
Volume:
208.5K
Avg. volume:
71.3K
1-year change:
-48.79%
Market cap:
$4.8M
Revenue:
$28.2M
EPS (TTM):
-$0.77

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MRAI
Marpai, Inc.
$8.7M -$0.43 -10.05% -74.41% --
CVS
CVS Health Corp.
$103.6B $1.00 1.11% 59.17% $96.38
HUM
Humana, Inc.
$32B -$3.99 19.94% -4.03% $223.88
PFHO
Pacific Health Care Organization, Inc.
-- -- -- -- --
RHEP
Regional Health Properties, Inc.
-- -- -- -- --
TALK
Talkspace, Inc.
$61.9M $0.03 23.09% 1196.11% $6.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MRAI
Marpai, Inc.
$0.47 -- $4.8M -- $0.00 0% 0.35x
CVS
CVS Health Corp.
$81.66 $96.38 $103.9B 59.02x $0.67 3.26% 0.26x
HUM
Humana, Inc.
$187.28 $223.88 $22.6B 19.09x $0.89 1.89% 0.17x
PFHO
Pacific Health Care Organization, Inc.
$1.2500 -- $16M 11.05x $0.10 0% 2.40x
RHEP
Regional Health Properties, Inc.
$1.30 -- $5.1M -- $0.00 0% 0.08x
TALK
Talkspace, Inc.
$4.93 $6.50 $816.7M 108.83x $0.00 0% 3.70x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MRAI
Marpai, Inc.
-47.21% 2.346 76.28% 0.51x
CVS
CVS Health Corp.
51.53% -0.127 79.13% 0.48x
HUM
Humana, Inc.
42.29% -0.185 41.78% 0.00x
PFHO
Pacific Health Care Organization, Inc.
-- 0.340 0.24% 28.77x
RHEP
Regional Health Properties, Inc.
94.22% -4.978 183.97% 0.22x
TALK
Talkspace, Inc.
-- -0.283 -- 6.25x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MRAI
Marpai, Inc.
$967K -$2.8M -- -- -68.64% $634K
CVS
CVS Health Corp.
$13.6B $2.3B 1.1% 2.28% 2.19% $2.6B
HUM
Humana, Inc.
-- -$808M 3.94% 6.77% -3.11% -$1.9B
PFHO
Pacific Health Care Organization, Inc.
$714.7K $205K 11.97% 11.97% 12.92% $23K
RHEP
Regional Health Properties, Inc.
$3.3M -$594K 0.21% -- -3.92% -$2.1M
TALK
Talkspace, Inc.
$26.1M $3.8M 6.84% 6.84% 6.08% $2.1M

Marpai, Inc. vs. Competitors

  • Which has Higher Returns MRAI or CVS?

    CVS Health Corp. has a net margin of -86.55% compared to Marpai, Inc.'s net margin of 2.77%. Marpai, Inc.'s return on equity of -- beat CVS Health Corp.'s return on equity of 2.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    MRAI
    Marpai, Inc.
    23.95% -$0.20 -$22.7M
    CVS
    CVS Health Corp.
    12.82% $2.30 $155.3B
  • What do Analysts Say About MRAI or CVS?

    Marpai, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand CVS Health Corp. has an analysts' consensus of $96.38 which suggests that it could grow by 18.03%. Given that CVS Health Corp. has higher upside potential than Marpai, Inc., analysts believe CVS Health Corp. is more attractive than Marpai, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    MRAI
    Marpai, Inc.
    0 0 0
    CVS
    CVS Health Corp.
    17 5 0
  • Is MRAI or CVS More Risky?

    Marpai, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.492, suggesting its less volatile than the S&P 500 by 50.806%.

  • Which is a Better Dividend Stock MRAI or CVS?

    Marpai, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.26% to investors and pays a quarterly dividend of $0.67 per share. Marpai, Inc. pays -- of its earnings as a dividend. CVS Health Corp. pays out 191.23% of its earnings as a dividend.

  • Which has Better Financial Ratios MRAI or CVS?

    Marpai, Inc. quarterly revenues are $4M, which are smaller than CVS Health Corp. quarterly revenues of $105.7B. Marpai, Inc.'s net income of -$3.5M is lower than CVS Health Corp.'s net income of $2.9B. Notably, Marpai, Inc.'s price-to-earnings ratio is -- while CVS Health Corp.'s PE ratio is 59.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marpai, Inc. is 0.35x versus 0.26x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRAI
    Marpai, Inc.
    0.35x -- $4M -$3.5M
    CVS
    CVS Health Corp.
    0.26x 59.02x $105.7B $2.9B
  • Which has Higher Returns MRAI or HUM?

    Humana, Inc. has a net margin of -86.55% compared to Marpai, Inc.'s net margin of -2.39%. Marpai, Inc.'s return on equity of -- beat Humana, Inc.'s return on equity of 6.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    MRAI
    Marpai, Inc.
    23.95% -$0.20 -$22.7M
    HUM
    Humana, Inc.
    -- -$6.61 $30.7B
  • What do Analysts Say About MRAI or HUM?

    Marpai, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Humana, Inc. has an analysts' consensus of $223.88 which suggests that it could grow by 19.54%. Given that Humana, Inc. has higher upside potential than Marpai, Inc., analysts believe Humana, Inc. is more attractive than Marpai, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    MRAI
    Marpai, Inc.
    0 0 0
    HUM
    Humana, Inc.
    6 17 2
  • Is MRAI or HUM More Risky?

    Marpai, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.440, suggesting its less volatile than the S&P 500 by 55.989%.

  • Which is a Better Dividend Stock MRAI or HUM?

    Marpai, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana, Inc. offers a yield of 1.89% to investors and pays a quarterly dividend of $0.89 per share. Marpai, Inc. pays -- of its earnings as a dividend. Humana, Inc. pays out 36% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MRAI or HUM?

    Marpai, Inc. quarterly revenues are $4M, which are smaller than Humana, Inc. quarterly revenues of $32.5B. Marpai, Inc.'s net income of -$3.5M is higher than Humana, Inc.'s net income of -$776M. Notably, Marpai, Inc.'s price-to-earnings ratio is -- while Humana, Inc.'s PE ratio is 19.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marpai, Inc. is 0.35x versus 0.17x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRAI
    Marpai, Inc.
    0.35x -- $4M -$3.5M
    HUM
    Humana, Inc.
    0.17x 19.09x $32.5B -$776M
  • Which has Higher Returns MRAI or PFHO?

    Pacific Health Care Organization, Inc. has a net margin of -86.55% compared to Marpai, Inc.'s net margin of 14.05%. Marpai, Inc.'s return on equity of -- beat Pacific Health Care Organization, Inc.'s return on equity of 11.97%.

    Company Gross Margin Earnings Per Share Invested Capital
    MRAI
    Marpai, Inc.
    23.95% -$0.20 -$22.7M
    PFHO
    Pacific Health Care Organization, Inc.
    45.04% $0.02 $12.8M
  • What do Analysts Say About MRAI or PFHO?

    Marpai, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pacific Health Care Organization, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Marpai, Inc. has higher upside potential than Pacific Health Care Organization, Inc., analysts believe Marpai, Inc. is more attractive than Pacific Health Care Organization, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    MRAI
    Marpai, Inc.
    0 0 0
    PFHO
    Pacific Health Care Organization, Inc.
    0 0 0
  • Is MRAI or PFHO More Risky?

    Marpai, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pacific Health Care Organization, Inc. has a beta of 0.097, suggesting its less volatile than the S&P 500 by 90.301%.

  • Which is a Better Dividend Stock MRAI or PFHO?

    Marpai, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pacific Health Care Organization, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.10 per share. Marpai, Inc. pays -- of its earnings as a dividend. Pacific Health Care Organization, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MRAI or PFHO?

    Marpai, Inc. quarterly revenues are $4M, which are larger than Pacific Health Care Organization, Inc. quarterly revenues of $1.6M. Marpai, Inc.'s net income of -$3.5M is lower than Pacific Health Care Organization, Inc.'s net income of $223K. Notably, Marpai, Inc.'s price-to-earnings ratio is -- while Pacific Health Care Organization, Inc.'s PE ratio is 11.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marpai, Inc. is 0.35x versus 2.40x for Pacific Health Care Organization, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRAI
    Marpai, Inc.
    0.35x -- $4M -$3.5M
    PFHO
    Pacific Health Care Organization, Inc.
    2.40x 11.05x $1.6M $223K
  • Which has Higher Returns MRAI or RHEP?

    Regional Health Properties, Inc. has a net margin of -86.55% compared to Marpai, Inc.'s net margin of 22.34%. Marpai, Inc.'s return on equity of -- beat Regional Health Properties, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    MRAI
    Marpai, Inc.
    23.95% -$0.20 -$22.7M
    RHEP
    Regional Health Properties, Inc.
    21.7% $1.17 $54.5M
  • What do Analysts Say About MRAI or RHEP?

    Marpai, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Regional Health Properties, Inc. has an analysts' consensus of -- which suggests that it could grow by 400%. Given that Regional Health Properties, Inc. has higher upside potential than Marpai, Inc., analysts believe Regional Health Properties, Inc. is more attractive than Marpai, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    MRAI
    Marpai, Inc.
    0 0 0
    RHEP
    Regional Health Properties, Inc.
    0 0 0
  • Is MRAI or RHEP More Risky?

    Marpai, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Regional Health Properties, Inc. has a beta of 1.054, suggesting its more volatile than the S&P 500 by 5.399%.

  • Which is a Better Dividend Stock MRAI or RHEP?

    Marpai, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Regional Health Properties, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Marpai, Inc. pays -- of its earnings as a dividend. Regional Health Properties, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MRAI or RHEP?

    Marpai, Inc. quarterly revenues are $4M, which are smaller than Regional Health Properties, Inc. quarterly revenues of $15.1M. Marpai, Inc.'s net income of -$3.5M is lower than Regional Health Properties, Inc.'s net income of $3.4M. Notably, Marpai, Inc.'s price-to-earnings ratio is -- while Regional Health Properties, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marpai, Inc. is 0.35x versus 0.08x for Regional Health Properties, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRAI
    Marpai, Inc.
    0.35x -- $4M -$3.5M
    RHEP
    Regional Health Properties, Inc.
    0.08x -- $15.1M $3.4M
  • Which has Higher Returns MRAI or TALK?

    Talkspace, Inc. has a net margin of -86.55% compared to Marpai, Inc.'s net margin of 7.56%. Marpai, Inc.'s return on equity of -- beat Talkspace, Inc.'s return on equity of 6.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    MRAI
    Marpai, Inc.
    23.95% -$0.20 -$22.7M
    TALK
    Talkspace, Inc.
    41.43% $0.03 $117M
  • What do Analysts Say About MRAI or TALK?

    Marpai, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Talkspace, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 31.85%. Given that Talkspace, Inc. has higher upside potential than Marpai, Inc., analysts believe Talkspace, Inc. is more attractive than Marpai, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    MRAI
    Marpai, Inc.
    0 0 0
    TALK
    Talkspace, Inc.
    6 1 0
  • Is MRAI or TALK More Risky?

    Marpai, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Talkspace, Inc. has a beta of 1.176, suggesting its more volatile than the S&P 500 by 17.627%.

  • Which is a Better Dividend Stock MRAI or TALK?

    Marpai, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Talkspace, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Marpai, Inc. pays -- of its earnings as a dividend. Talkspace, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MRAI or TALK?

    Marpai, Inc. quarterly revenues are $4M, which are smaller than Talkspace, Inc. quarterly revenues of $63M. Marpai, Inc.'s net income of -$3.5M is lower than Talkspace, Inc.'s net income of $4.8M. Notably, Marpai, Inc.'s price-to-earnings ratio is -- while Talkspace, Inc.'s PE ratio is 108.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Marpai, Inc. is 0.35x versus 3.70x for Talkspace, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MRAI
    Marpai, Inc.
    0.35x -- $4M -$3.5M
    TALK
    Talkspace, Inc.
    3.70x 108.83x $63M $4.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
37
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
50
AXTI alert for Mar 3

AXT, Inc. [AXTI] is up 22.11% over the past day.

Buy
53
AAOI alert for Mar 3

Applied Optoelectronics, Inc. [AAOI] is up 21.71% over the past day.

Sell
32
TPB alert for Mar 3

Turning Point Brands, Inc. [TPB] is down 20.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock